Is Compounded Semaglutide the Same as Ozempic®?
Same active ingredient, different product, different FDA standing. Here is the clear, current, physician-reviewed answer — and what actually matters for your safety.
Medically reviewed by Charles Kamen, MD, board-certified neurologist ·
Compounded semaglutide and Ozempic contain the same active ingredient — semaglutide, a GLP-1 receptor agonist — but they are not the same product. Ozempic is a specific FDA-approved finished drug, manufactured by Novo Nordisk with a fixed formulation, standardized labeling, and ongoing FDA quality oversight. Compounded semaglutide is prepared by a licensed compounding pharmacy and is not itself an FDA-approved finished drug.
That difference is the whole answer to the question, and it has three practical parts: what “FDA-approved” actually covers, when compounding semaglutide is legally permitted, and how to make sure what you receive is safely sourced. We are a physician practice, not a medication retailer, so the goal here is to explain the distinction clearly — the decision itself belongs in a medical evaluation.
What does “FDA-approved” cover here?
FDA approval applies to specific finished products, not to a molecule in general. Novo Nordisk’s semaglutide products — Ozempic and Rybelsus for type 2 diabetes, and Wegovy for chronic weight management — are FDA-approved finished drugs. Compounded semaglutide uses the same active ingredient but is a pharmacy preparation, not an approved product, so it does not carry the same approved standing even though the molecule is identical. This is the same principle covered on our which peptides are FDA-approved reference: the useful question is always which exact product, not just the ingredient name.
When is compounding semaglutide permitted?
Compounding a drug that copies an FDA-approved product is generally restricted under federal law, with an important exception during periods when the FDA lists the drug as in shortage. Semaglutide appeared on the FDA shortage list during 2022–2024, which broadened compounding; the FDA later declared the shortage resolved, which narrowed it again. Because shortage status and the resulting compounding eligibility shift over time, this is exactly the kind of fact to verify at the time of care rather than assume from any web page. Our FDA compounding status tracker explains why these distinctions matter and change.
How do you source compounded semaglutide safely?
Safety comes down to sourcing. Legitimate compounded semaglutide is dispensed by a licensed 503A or 503B pharmacy after a physician evaluation, with third-party purity and potency testing. The danger is the unregulated market — “research use only” vials, unverified powders, and “semaglutide salt” products that are not made or tested for human use.
Ozempic, Wegovy, and Rybelsus are FDA-approved finished drugs — same molecule, distinct products
No compounded drug is FDA-approved, including compounded semaglutide
Compounding eligibility tracks FDA shortage status, which changes over time
Legitimate compounded semaglutide comes from a licensed 503A/503B pharmacy with a prescription
Avoid "research use only" or "semaglutide salt" products — not made or tested for human use
Whether a GLP-1 is right for you is a physician decision, never a checkout decision
Compounded Semaglutide vs Ozempic — FAQ
Is compounded semaglutide the same as Ozempic?
No. Compounded semaglutide and Ozempic share the same active ingredient — semaglutide, a GLP-1 receptor agonist — but they are not the same product. Ozempic is a specific FDA-approved finished drug manufactured by Novo Nordisk with a fixed formulation, labeling, and quality oversight. Compounded semaglutide is prepared by a licensed compounding pharmacy and is not an FDA-approved finished drug. Same molecule, different product, different regulatory standing.
Is compounded semaglutide FDA-approved?
No compounded drug is FDA-approved, including compounded semaglutide. The FDA approves specific finished products such as Ozempic, Wegovy, and Rybelsus — not compounded preparations. Compounded semaglutide is made by a licensed 503A or 503B pharmacy under state and federal compounding rules; the individual preparation has not gone through the FDA new-drug approval process even when the active ingredient is the same.
When is compounding semaglutide legally permitted?
Compounding of a drug that copies an FDA-approved product is generally restricted under federal law, with a notable exception for periods when the FDA lists the drug as in shortage. Semaglutide was on the FDA shortage list during 2022–2024, which expanded compounding; the FDA subsequently declared the shortage resolved, which narrowed it. Because shortage status and compounding eligibility change over time, the only reliable answer for your situation is one a licensed physician and pharmacy can confirm at the time of care.
Is compounded semaglutide safe?
Safety depends almost entirely on sourcing. Compounded semaglutide from a licensed 503A or 503B pharmacy, dispensed after a physician evaluation with third-party purity and potency testing, is a regulated medical preparation. Products sold online as "research use only" semaglutide, or unverified powders and "salt forms," are not made or tested for human use and carry real risk. The FDA has warned about adverse events linked to compounded and counterfeit GLP-1 products from unregulated sources. Individual results and risks vary and must be assessed by a physician.
What is the difference between Ozempic and Wegovy?
Ozempic and Wegovy are both brand-name semaglutide made by Novo Nordisk, but they are FDA-approved for different uses: Ozempic is approved for type 2 diabetes, and Wegovy is approved for chronic weight management. Rybelsus is an oral form of semaglutide approved for type 2 diabetes. All three are FDA-approved finished drugs — distinct from compounded semaglutide.
Should I choose compounded semaglutide or brand-name Ozempic?
That is a medical decision, not a shopping decision, and it depends on your health profile, insurance, availability, and clinical goals. A legitimate physician evaluates whether a GLP-1 medication is appropriate for you at all, then discusses FDA-approved options and, where compounding is permitted and appropriate, licensed-pharmacy compounded options — with honest information about the regulatory and safety differences. No web page can make that call for you.
How do I avoid fake or unsafe compounded semaglutide?
Use a physician-led clinic that dispenses only through a named, licensed 503A or 503B compounding pharmacy, requires a valid prescription after evaluation, and can provide certificates of analysis showing third-party testing. Avoid any vendor selling semaglutide directly without a prescription, labeling it "research use only," or marketing unverified "semaglutide salt" — these are the hallmarks of gray-market and counterfeit products.
Related reading: 503A vs 503B compounding pharmacies · Semaglutide in Las Vegas · GLP-1 medications compared
Physician-Led in Las Vegas
Questions about semaglutide? Ask a physician.
Whether a GLP-1 medication fits your health is a clinical decision. Start with an $88 medical evaluation, and Dr. Kamen will review your options honestly — FDA-approved and, where appropriate, licensed-pharmacy compounded — with transparent sourcing.
Ready to Start Your Longevity Journey?
Book your $88 evaluation with Dr. Kamen today — online, by phone, or by text.
Book Your $88 EvaluationPrefer to talk? Call (702) 808-2650 or text us to book.
physician-led peptide therapy Las Vegas — visit our clinic